While serum albumin-to-creatinine ratio (sACR) has been studied in the context of cardiovascular diseases such as myocardial infarction, heart failure, and sepsis (7–9), its association with cerebrovascular pathology, and specifically with silent cerebral infarction (SCI), has not been previously explored. The gene discussed is ALB; the disease is myocardial infarction.